Meta-Analysis of Long-Term (>1 Year) Cardiac Outcomes of Peripartum Cardiomyopathy.

[1]  J. Kuller,et al.  Peripartum Cardiomyopathy , 2021, Obstetrical & gynecological survey.

[2]  A. Bortnick,et al.  Persistence of abnormal global longitudinal strain in women with peripartum cardiomyopathy , 2021, Echocardiography.

[3]  E. Potapov,et al.  The outcome of patients with peripartum cardiomyopathy and consecutive implantation of a left ventricular assist device , 2021, Journal of cardiac surgery.

[4]  K. Sliwa,et al.  Biomarkers and their relation to cardiac function late after peripartum cardiomyopathy. , 2021, Journal of cardiac failure.

[5]  L. Cooper,et al.  A Case-Control Study of Peripartum Cardiomyopathy Using the Rochester Epidemiology Project , 2020, Journal of cardiac failure.

[6]  A. Binu,et al.  Peripartum cardiomyopathy: An analysis of clinical profiles and outcomes from a tertiary care centre in southern India , 2020, Obstetric medicine.

[7]  S. Stewart,et al.  Clinical Features and Outcomes of Peripartum Cardiomyopathy in Nigeria. , 2020, Journal of the American College of Cardiology.

[8]  Jeong Hoon Yang,et al.  Clinical characteristics and long‐term outcomes of peripartum takotsubo cardiomyopathy and peripartum cardiomyopathy , 2020, ESC heart failure.

[9]  K. Karaye,et al.  Selenium supplementation in patients with peripartum cardiomyopathy: a proof-of-concept trial , 2020, BMC Cardiovascular Disorders.

[10]  Ke Wan,et al.  Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping , 2020, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[11]  J. Bauersachs,et al.  Long‐term follow‐up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co‐morbidities , 2019, European journal of heart failure.

[12]  O. Ozeke,et al.  Fragmented QRS as a candidate marker for left ventricular nonrecovery in patients with peripartum cardiomyopathy , 2019, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[13]  Yidan Wang,et al.  Association of autoantibodies against the M2-muscarinic receptor with long-term outcomes in peripartum cardiomyopathy patients: A 5-year prospective study. , 2019, Journal of cardiology.

[14]  S. Cay,et al.  A novel marker of persistent left ventricular systolic dysfunction in patients with peripartum cardiomyopathy: monocyte count- to- HDL cholesterol ratio , 2019, BMC Cardiovascular Disorders.

[15]  O. Ozeke,et al.  The prognostic value of positive T wave in lead aVR: A novel marker of adverse cardiac outcomes in peripartum cardiomyopathy , 2019, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[16]  Melinda B Davis,et al.  Long-term Outcomes in Peripartum Cardiomyopathy , 2019, The Open Cardiovascular Medicine Journal.

[17]  G. Marcus,et al.  Pregnancy complications and premature cardiovascular events among 1.6 million California pregnancies , 2019, Open Heart.

[18]  P. Damm,et al.  Long‐Term Cardiac Function After Peripartum Cardiomyopathy and Preeclampsia: A Danish Nationwide, Clinical Follow‐Up Study Using Maximal Exercise Testing and Cardiac Magnetic Resonance Imaging , 2018, Journal of the American Heart Association.

[19]  Z. Asad,et al.  Peripartum cardiomyopathy: A systematic review of the literature , 2018, Clinical cardiology.

[20]  M. Schaufelberger,et al.  Symptomatic recovery and pharmacological management in a clinical cohort with peripartum cardiomyopathy , 2018, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[21]  M. Baldwin,et al.  Initial Right Ventricular Dysfunction Severity Identifies Severe Peripartum Cardiomyopathy Phenotype With Worse Early and Overall Outcomes: A 24‐Year Cohort Study , 2018, Journal of the American Heart Association.

[22]  P. Demondion,et al.  Heart Transplantation for Peripartum Cardiomyopathy: A Single-Center Experience , 2018, Arquivos brasileiros de cardiologia.

[23]  Şukru Aksoy,et al.  Value of the neutrophil-to-lymphocyte ratio in predicting left ventricular recovery in patients with peripartum cardiomyopathy , 2017, Wiener klinische Wochenschrift.

[24]  P. Kaul,et al.  Association Between Diabetes During Pregnancy and Peripartum Cardiomyopathy: A Population-Level Analysis of 309,825 Women. , 2017, The Canadian journal of cardiology.

[25]  Shao‐Wei Chen,et al.  Comparison of clinical outcomes in peripartum cardiomyopathy and age-matched dilated cardiomyopathy , 2017, Medicine.

[26]  K. Gage,et al.  Cardiac Magnetic Resonance Imaging in Oncology. , 2017, Cancer control : journal of the Moffitt Cancer Center.

[27]  A. Fürnkranz,et al.  Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysis , 2017, Clinical Research in Cardiology.

[28]  L. Cuenza,et al.  Clinical Profi le and Predictors of Outcomes of Patients with Peripartum Cardiomyopathy: The Philippine Heart Center Experience , 2016, ASEAN heart journal : Official journal of the ASEAN Federation of Cardiology.

[29]  A. Briasoulis,et al.  Longitudinal systolic strain profiles and outcomes in peripartum cardiomyopathy , 2016, Echocardiography.

[30]  Hongwei Li,et al.  Clinical Characteristics and Long-term Predictors of Persistent Left Ventricular Systolic Dysfunction in Peripartum Cardiomyopathy. , 2016, The Canadian journal of cardiology.

[31]  M. Ozdemir,et al.  Peripartum cardiomyopathy in Turkey: Experience of three tertiary centres , 2016, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[32]  K. Sliwa,et al.  Pregnancy-Associated Heart Failure: A Comparison of Clinical Presentation and Outcome between Hypertensive Heart Failure of Pregnancy and Idiopathic Peripartum Cardiomyopathy , 2015, PloS one.

[33]  Anas Alani,et al.  Peripartum cardiomyopathy: predictors of recovery and current state of implantable cardioverter-defibrillator use. , 2014, Journal of the American College of Cardiology.

[34]  D. Kolte,et al.  Temporal Trends in Incidence and Outcomes of Peripartum Cardiomyopathy in the United States: A Nationwide Population‐Based Study , 2014, Journal of the American Heart Association.

[35]  I. Goldenberg,et al.  Peripartum cardiomyopathy – risk factors, characteristics and long-term follow-up , 2014, Journal of perinatal medicine.

[36]  R. Starling,et al.  Outcomes of Patients With Peripartum Cardiomyopathy Who Received Mechanical Circulatory Support: Data From the Interagency Registry for Mechanically Assisted Circulatory Support , 2014, Circulation. Heart failure.

[37]  K. Sliwa,et al.  Predictors of outcome in 176 South African patients with peripartum cardiomyopathy , 2012, Heart.

[38]  B. Bozkurt,et al.  Delayed recovery in peripartum cardiomyopathy: an indication for long‐term follow‐up and sustained therapy , 2012, European journal of heart failure.

[39]  N. Lamblin,et al.  Unexpected and rapid recovery of left ventricular function in patients with peripartum cardiomyopathy: impact of cardiac resynchronization therapy , 2012, European journal of heart failure.

[40]  Cathleen K. Yoshida,et al.  Epidemiology of Peripartum Cardiomyopathy: Incidence, Predictors, and Outcomes , 2011, Obstetrics and gynecology.

[41]  L. Rohde,et al.  Asymptomatic left ventricular dysfunction in puerperal women: an echocardiographic-based study. , 2011, International journal of cardiology.

[42]  S. Goland,et al.  Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. , 2011, Journal of cardiac failure.

[43]  M. de Pauw,et al.  Acute and critically ill peripartum cardiomyopathy and 'bridge to' therapeutic options: a single center experience with intra-aortic balloon pump, extra corporeal membrane oxygenation and continuous-flow left ventricular assist devices , 2011, Critical care.

[44]  K. Sliwa,et al.  Long-term outcome of peripartum cardiomyopathy in a population with high seropositivity for human immunodeficiency virus. , 2011, International journal of cardiology.

[45]  K. Sliwa,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy , 2010, European journal of heart failure.

[46]  David Nunan,et al.  The impact of acute reduction of continuous-flow left ventricular assist device support on cardiac and exercise performance , 2010, Heart.

[47]  J. Copeland,et al.  Treatment of peripartum cardiomyopathy with mechanical assist devices and cardiac transplantation. , 2010, The Annals of thoracic surgery.

[48]  S. Goland,et al.  Clinical profile and predictors of complications in peripartum cardiomyopathy. , 2009, Journal of cardiac failure.

[49]  G. Caldito,et al.  Poor outcome of indigent patients with peripartum cardiomyopathy in the United States. , 2009, American journal of obstetrics and gynecology.

[50]  J. Fett,et al.  Recovery from severe heart failure following peripartum cardiomyopathy , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[51]  Thomas V. O'brien,et al.  Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. , 2008, American journal of obstetrics and gynecology.

[52]  N. Lamblin,et al.  Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging , 2008, European Radiology.

[53]  M. Özkan,et al.  Predictors of prognosis in patients with peripartum cardiomyopathy , 2008, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[54]  D. Renlund,et al.  Long-term outcomes of cardiac transplantation for peri-partum cardiomyopathy: a multiinstitutional analysis. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[55]  Steven S. Khan,et al.  Incidence, mortality, and racial differences in peripartum cardiomyopathy. , 2007, The American journal of cardiology.

[56]  B. Maisch,et al.  Clinical and immunologic characteristics in peripartum cardiomyopathy. , 2007, International journal of cardiology.

[57]  S. Routray,et al.  Peripartum cardiomyopathy , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[58]  S. Russell,et al.  Improved outcomes in peripartum cardiomyopathy with contemporary. , 2006, American heart journal.

[59]  L. Christie,et al.  Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. , 2005, Mayo Clinic proceedings.

[60]  L. Weinert,et al.  Prognostic Value of Echocardiography in Peripartum Cardiomyopathy , 2005, Obstetrics and gynecology.

[61]  R H Hruban,et al.  Myocarditis and long-term survival in peripartum cardiomyopathy. , 2000, American heart journal.

[62]  R H Hruban,et al.  Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. , 2000, The New England journal of medicine.

[63]  S. Hunt,et al.  Long-term outcome after heart transplantation for peripartum cardiomyopathy. , 1994, American heart journal.

[64]  L. Favaloro,et al.  Predictors of Mortality or Heart Transplantation in Peripartum Cardiomyopathy , 2013 .

[65]  L. Cooper,et al.  Myocardial recovery in peripartum cardiomyopathy: prospective comparison with recent onset cardiomyopathy in men and nonperipartum women. , 2012, Journal of cardiac failure.

[66]  S. Szymkiewicz,et al.  Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator. , 2012, Journal of cardiac failure.

[67]  S. Gündüz,et al.  Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial , 2010, Clinical Research in Cardiology.

[68]  E. Simoes,et al.  [Clinical characteristics associated with unfavorable outcomes in peripartum myocardiopathy]. , 2005, Arquivos brasileiros de cardiologia.